| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017842159 |
| P356 | DOI | 10.1038/NPP.2013.223 |
| P932 | PMC publication ID | 3870775 |
| P698 | PubMed publication ID | 23985782 |
| P5875 | ResearchGate publication ID | 256200409 |
| P50 | author | Sade Spencer | Q54963468 |
| Robyn Mary Brown | Q59679665 | ||
| P2093 | author name string | Peter W Kalivas | |
| Charles A Thomas | |||
| Kathryn J Reissner | |||
| Phuong K Tran | |||
| P2860 | cites work | Propentofylline for dementia | Q24248786 |
| Molecular dissection of reactive astrogliosis and glial scar formation | Q24646628 | ||
| The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia | Q24650739 | ||
| Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking | Q24656626 | ||
| Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances | Q27003932 | ||
| Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene | Q28143941 | ||
| Molecular pharmacology of glutamate transporters, EAATs and VGLUTs | Q28267974 | ||
| The mystery and magic of glia: a perspective on their roles in health and disease | Q28300305 | ||
| Similar perisynaptic glial localization for the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex | Q28565563 | ||
| A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation | Q28728678 | ||
| AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis | Q33871972 | ||
| Astrocyte activation and reactive gliosis | Q34413317 | ||
| Clinical trials in dementia with propentofylline | Q34442191 | ||
| Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. | Q34683123 | ||
| Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation | Q72310404 | ||
| Brain circuitry and the reinstatement of cocaine-seeking behavior | Q35090481 | ||
| Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice | Q35103692 | ||
| Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking | Q35206834 | ||
| Microglia: scapegoat, saboteur, or something else? | Q35606301 | ||
| Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression | Q35676825 | ||
| Methamphetamine-induced changes in the object recognition memory circuit. | Q35685517 | ||
| Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference | Q36234303 | ||
| Time course of cocaine-induced behavioral and neurochemical plasticity | Q36476456 | ||
| The neurocircuitry of addiction: an overview | Q36741890 | ||
| Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. | Q36895496 | ||
| Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats | Q37332208 | ||
| Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention | Q37504026 | ||
| The glutamate homeostasis hypothesis of addiction | Q37538517 | ||
| Chronic obstructive pulmonary disease in the elderly: an update on pharmacological management | Q37547193 | ||
| Propentofylline: Glial Modulation, Neuroprotection, and Alleviation of Chronic Pain | Q37791043 | ||
| Methylxanthines in Asthma | Q37791055 | ||
| Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system | Q37891461 | ||
| Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection | Q39022447 | ||
| Extracellular glutamate: functional compartments operate in different concentration ranges. | Q40255443 | ||
| Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell | Q42176447 | ||
| Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats | Q42577543 | ||
| Use of vivo-morpholinos for control of protein expression in the adult rat brain | Q42827488 | ||
| Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. | Q43611011 | ||
| The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex | Q43818696 | ||
| mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine. | Q44371889 | ||
| Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration | Q44386846 | ||
| Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. | Q44396263 | ||
| Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. | Q44419020 | ||
| Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence | Q45282164 | ||
| Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model | Q46416922 | ||
| The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. | Q46670474 | ||
| Glutamate release in the nucleus accumbens core is necessary for heroin seeking. | Q46691821 | ||
| Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia | Q46856174 | ||
| Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse | Q46890942 | ||
| The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice | Q48161288 | ||
| The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine | Q48170762 | ||
| Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials | Q48377780 | ||
| A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. | Q51999001 | ||
| Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. | Q52060963 | ||
| Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. | Q52272976 | ||
| Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers. | Q53225758 | ||
| Identification of propentofylline metabolites in rats by gas chromatography/mass spectrometry. | Q53237523 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 499-506 | |
| P577 | publication date | 2013-08-29 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism | |
| P478 | volume | 39 |
| Q33923637 | A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype |
| Q37138642 | Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies |
| Q26996339 | Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis |
| Q47680320 | Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis |
| Q38805967 | Corticostriatal circuitry in regulating diseases characterized by intrusive thinking |
| Q35077751 | Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats |
| Q89886242 | Effects of Cocaine Exposure on Astrocytic Glutamate Transporters and Relapse-Like Ethanol-Drinking Behavior in Male Alcohol-Preferring Rats |
| Q35533496 | Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats. |
| Q47563473 | Effects of muscarinic M1 and M4 acetylcholine receptor stimulation on extinction and reinstatement of cocaine seeking in male mice, independent of extinction learning. |
| Q53333507 | Effects of repeated cocaine exposure and withdrawal on voluntary ethanol drinking, and the expression of glial glutamate transporters in mesocorticolimbic system of P rats. |
| Q38729846 | Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse |
| Q28081726 | Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders |
| Q38512084 | Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease |
| Q35623912 | Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement |
| Q28392199 | HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads |
| Q35007339 | Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors |
| Q47284247 | Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior |
| Q35153407 | Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment |
| Q57133047 | Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal |
| Q42100637 | Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A 2A receptors during extinction training in rats |
| Q47789766 | Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal |
| Q48027976 | Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression. |
| Q37062831 | Sign-trackers have elevated myo-inositol in the nucleus accumbens and ventral hippocampus following Pavlovian conditioned approach. |
| Q37705513 | Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse |
| Q37062547 | The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis |
Search more.